Cited by

• Assessing Stroke Recurrence Risk by Using a Lipoprotein-Associated Phospholipase A2 and Platelet Count-Based Nomogram.

  Zhou Y, Feng Y, Xin N, Lu J, Xu X. Zhou Y, et al. Mol Neurobiol. 2024 Aug 23. doi: 10.1007/s12035-024-04439-3. Online ahead of print. Mol Neurobiol. 2024. PMID: 39177733
• Efficacy and safety of short-term high dosage dual antiplatelet therapy after 0.6 mg/kg rt-PA intravenous thrombolysis for acute ischemic stroke.

  Chen J, Lin Y, Li J, Zhang P, Wang Y, Chen Y, Zhang C, Li C. Chen J, et al. Medicine (Baltimore). 2023 Sep 8;102(36):e35099. doi: 10.1097/MD.0000000000035099. Medicine (Baltimore). 2023. PMID: 37682162 Free PMC article. Clinical Trial.
• Dual Versus Mono Antiplatelet Therapy in Patients with Acute Mild-to-Moderate Stroke: A Multicentre Perspective Cohort Study.

  Zhang K, Liu T, Fan H, Wang Y, Li Y, Li J, Li Y, Yu Y, Wang J, Xue L, Du W, Niu W, Yan Y, Gao X, Li G, Liu Q, Liu Y, Fan Y, Ren J, Li X, Wu X, Niu X. Zhang K, et al. Cardiovasc Drugs Ther. 2023 Jun 13. doi: 10.1007/s10557-023-07468-7. Online ahead of print. Cardiovasc Drugs Ther. 2023. PMID: 37310551
• Human Serum Albumin-enriched Clopidogrel Bisulfate Nanoparticle Alleviates Cerebral Ischemia-Reperfusion Injury in Rats.

  Luo Y, Xia Y, Zhang H, Lin Y, He L, Gong T, Zhang Z, Deng L. Luo Y, et al. Pharm Res. 2023 Jul;40(7):1821-1833. doi: 10.1007/s11095-023-03543-8. Epub 2023 Jun 8. Pharm Res. 2023. PMID: 37291463
• Time Course for Benefit and Risk of Ticagrelor and Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack.

  Wang Y, Pan Y, Li H, Amarenco P, Denison H, Evans SR, Himmelmann A, James S, Knutsson M, Ladenvall P, Molina CA, Johnston SC. Wang Y, et al. Neurology. 2022 Jul 5;99(1):e46-e54. doi: 10.1212/WNL.0000000000200355. Epub 2022 Apr 18. Neurology. 2022. PMID: 35437261 Free PMC article.